Browsing: Interviews


In this interview Robert Nelson, Associate Director of Science and Innovation at Covance (Geneva, Switzerland) discusses the importance of biomarkers in drug development, describing key aspects in the current guidance and key considerations to make in the development and validation process.


In this interview Joel Mathews (Ionis Pharmaceuticals Inc., CA, USA) discusses his role in the development of biomarker, PK and immunogenicity assays in the development of protein therapeutics. He explains his interest in the field and explores the use of LBA for biomarker validation

BOSCA winner 2019

Bioanalysis Zone is proud to announce the 2019 Bioanalysis Outstanding Contribution Award winner – find out who has won this year’s award here!

1 2 3 4 26